Abstract
Two simple and sensitive validated spectrophotometric methods have been described for the assay of nicorandil in drug formulations. Method A is based on the reaction of the drug with phloroglucinol-sulfanilic acid reagent in sulfuric acid medium to give yellow-colored product, which absorbs maximally at 425 nm. Method B uses the oxidative coupling of 3-methyl-2-benzothiazolinone hydrazone hydrochloride (MBTH) with DL-3,4-dihydroxyphenylalanine (DL-dopa) in the presence of nicorandil as oxidant in sulfuric acid medium to form an intensely colored product having maximum absorbance at 530 nm. Beer's law is obeyed in the concentration range 2.5 to 50.0 and 1.0 to 15.0 μg mL−1 with methods A and B, respectively. Both methods have been successfully applied for the analysis of drug in pharmaceutical formulations. The reliability and the performance of the proposed methods are established by point and interval hypothesis and through recovery studies. The experimental true bias of all samples is smaller than ±2%.
Similar content being viewed by others
References
Frampton J, Buckley MM, Fitton A. Nicorandil: a review of its pharmacology and therapeutic efficacy in angina pectoris.Drugs. 1992;44:625–655.
Markham A, Plosker GL, Goa KL. Nicorandil: an updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.Drugs. 2000;60:955–974.
Royal Pharmaceutical Society.Martindale: The Extra Pharmacopoeia. 33rd ed. London, UK: Royal Pharmaceutical Society; 2002:939.
Tipre DN, Vavia PR. Degradation kinetic study of nicorandil using HPTLC method.Indian Drugs. 2000;37:412–416.
Schwende FJ, Lewis RC. Determination of nicorandil in plasma using high-performance liquid chromatography with photoconductivity and ultra violet detection: application to pre-clinical pharmacokinetics in beagle dogs.J Chromatogr B Biomed Sci Appl. 1990;525:151–160.
Gomiti Y, Furuno K, Eto K, et al. Rapid and simple determination of nicorandil in rat plasma using solid-phase extraction column.J Chromatogr B Biomed Sci Appl. 1990;528:509–516.
Ishizaki T, Chiba K, Suganuma T, Sasaki T, Kamiyama H, Nakano H. Pharmacokinetics of nicorandil, a new coronary vasodilator in dogs.J Pharm Sci. 1984;73:494–498.
Tanikawa M, Uzu M, Ohsawa Y, Fukishima M. Sensitive method for determination of nicorandil in human plasma by reversed phase HPLC with UV detection.J Chromtogr B Biomed Appl. 1993;617:163–167.
Bachert EL, Fung HL. High performance liquid chromatographic method for stability and pharmacokinetic studies on nicorandil.J Chromatogr B Biomed Appl. 1993;619:336–341.
Ojha A, Pargal A. Determination of nicorandil concentrations in human plasma using liquid chromatography.J Pharm BiomedAnal. 1999;21:175–178.
Frydman A. Pharmacokinetic profile of nicorandil in humans: an overview.J Cardiovasc Pharmacol. 1992;20(suppl 3):S34-S44.
Frydman AM, Chapelle P, Dickmann H, et al. Pharmacokinetics of nicorandil.Am J Cardiol. 1989;63:25J-33J.
Massart DL, Vandeginste BGM, Deming SN, Michotte Y, Kaufmann L.Chemometrics, A Textbook. Amsterdam, The Netherlands: Elsevier, 1988.
Belamy AJ, Golding P, Ward SJ, inventors. Synthesis of ammonium diaminopicrate from trihydroxybenzene as candidate novel insensitive explosive. UK Patent Application No. GB 2 355 714 (CL C07C211/52) May 2, 2001, Appl. 1999/25, 151, 26 Oct 1999; 18 pp.
Bartsch RA, Hunig S, Quast H. Mechanism of oxidation of 3-methyl-2-benzothiazolinone hydrazone hydrochloride by potassium ferricyanide in aqueous methanol.J Am Chem Soc. 1970;92:6007–6011.
Gasparic J, Svobodova D, Pospisilova M. Identification of organic compounds. Part LXXXVI. Investigation of the color reaction of phenols with the MBTH (3-methyl-2-benzothiazolinone hydrazone hydrochloride) reagent.Mikrochim Acta. 1977;1:241–250.
Morelli B. Determination of ternary mixtures of antibiotics, by ratiospectra zero-crossing first- and third-derivative spectrophotometry.J Pharm Biomed Anal. 1995;13:219–277.
Morelli B. “Zero crossing” Derivative spectrophotometric determination of mixtures of cephapirin sodium and cefuroxime sodium in pure form and in injections.Analyst. 1988;113:1077–1082.
Morelli B. Determination of a tertiary mixture of pencillin-G sodium salt, pencillin-G procain salt and dihyro streptomycin sulphate by third-derivative spectrophotometry.Takanta. 1994;41:479–483.
Morelli B. Simultaneous determination of ceftriaxone and streptomycin in mixture by ratio-spectra, 2nd derivative and zero crossing 3rd derivative spectrophotometry.Talanta. 1994;41:673–683.
Nallimov VV.The Application of Mathematical Statistics to Chemical Analysis. Oxford, UK: Pergamon Press; 1963.
Miller JN. Basic statistical methods for analytical chemistry. Part 2. Calibration and regression methods.Analysis. 1991;116:3–14.
Cassidy R, Janoski M. Is your calibration linear?LC GC. 1992;10:692–695.
Christian GD.Analytical Chemistry. 4th ed. Singapore: John Wiley and Sons; 1994.
Hartmann C, Smeyers-Verbeke J, Pinninckx W, Heyden YV, Vankeerberghen P, Massart DL. Reappraisal of hypothesis testing for method validation: detection of systematic error by comparing the means of two methods or of two laboratories.Anal Chem. 1995;67:4491–4499.
Jelliffe RW, Maire P, Sattler F, Gomis P, Tahani B. Adaptive control of drug dosage regimens: basic foundations, relevant issues and clinical examples.Int J Biomed Comput. 1994;36:1–23.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: November 30, 2004.
Rights and permissions
About this article
Cite this article
Rahman, N., Ahmad, Y. & Azmi, S.N.H. Selective and validated spectrophotometric methods for the determination of nicorandil in pharmaceutical formulations. AAPS J 6, 34 (2004). https://doi.org/10.1208/aapsj060434
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/aapsj060434